Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 γ chain-deficient mice

Biological Chemistry

Volumn 390, Issue 9, 2009, Pages 893-897

  Raggi, Matthias C ^a   Djafarzadeh, Roghieh ^b   Muenchmeier, Niklas ^b   Hofstetter, Monika ^b   Jahn, Birgit ^b   Rieth, Nicole ^b   Nelson, Peter J ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Colorectal cancer; Matrix metalloproteinases; Proliferation; TIMP 1 GPI; Tissue inhibitors of metalloproteinases

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PROTEINASE; RAG2 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

MUS;

EID: 70349452029     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.098     Document Type: Article

References (23)

1. Almholt, K. and Johnsen, M. (2003). Stromal cell involvement in cancer. Recent Results Cancer Res. 162, 31-42.
2. Chirco, R., Liu, X.W., Jung, K.K., and Kim, H.R. (2006). Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 25, 99-113.
3. Cockett, M.I., Birch, M.L., Murphy, G., Hart, I.R., and Docherty, A.J. (1994). Metalloproteinase domain structure, cellular invasion and metastasis. Biochem. Soc. Trans. 22, 55-57.
4. Cox, G. and O'Byrne, K.J. (2001). Matrix metalloproteinases and cancer. Anticancer Res. 21, 4207-4219.
5. Djafarzadeh, R., Mojaat, A., Vicente, A.B., von Luttichau, I., and Nelson, P.J. (2004). Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities. Biol. Chem. 385, 655-663.
6. Djafarzadeh, R., Noessner, E., Engelmann, H., Schendel, D.J., Notohamiprodjo, M., von Luettichau, I., and Nelson, P.J. (2006). GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-mediated killing. Oncogene 25, 1496-1508.
7. Djafarzadeh, R., Milani, V., Rieth, N., von Luettichau, I., Skrablin, P.S., Hofstetter, M., Noessner, E., and Nelson, P.J. (2009). TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis. Cancer Immunol. Immunother. 58, 361-371.
8. Klier, C.M., Nelson, E.L., Cohen, C.D., Horuk, R., Schlondorff, D., and Nelson, P.J. (2001). Chemokine-induced secretion of gelatinase B in primary human monocytes. Biol. Chem. 382, 1405-1410.
9. Maskos, K. and Bode, W. (2003). Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Mol. Biotechnol. 25, 241-266.
10. Matsuyama, Y., Takao, S., and Aikou, T. (2002). Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J. Surg. Oncol. 80, 105-110.
11. McCawley, L.J. and Matrisian, L.M. (2001). Tumor progression: defining the soil round the tumor seed. Curr. Biol. 11, R25- R27
12. Medof, M.E., Nagarajan, S., and Tykocinski, M.L. (1996). Cellsurface engineering with GPI-anchored proteins. FASEB J. 10, 574-586.
13. Mimori, K., Yamashita, K., Ohta, M., Yoshinaga, K., Ishikawa, K., Ishii, H., Utsunomiya, T., Barnard, G.F., Inoue, H., and Mori, M. (2004). Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells. Clin. Cancer Res. 10, 8243-8249.
14. Murray, J.C., Symonds, P., Ward, W., Huggins, M., Tiga, A., Rice, K., Heng, Y.M., Todd, I., and Robins, R.A. (2004). Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II- dependent mechanism. J. Immunol. 172, 274-281.
15. Mylona, E., Kapranou, A., Mavrommatis, J., Markaki, S., Keramopoulos, A., and Nakopoulou, L. (2005). The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer. Acta Pathol. Microbiol. Immunol. Scand. 113, 246-255.
16. Nagase, H., Visse, R., and Murphy, G. (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562-573.
17. Nagashima, Y., Hasegawa, S., Koshikawa, N., Taki, A., Ichikawa, Y., Kitamura, H., Misugi, K., Kihira, Y., Matuo, Y., Yasumitsu, H., et al. (1997). Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int. J. Cancer 72, 441-445.
18. Oshima, T., Akaike, M., Yoshihara, K., Shiozawa, M., Yamamoto, N., Sato, T., Yamada, R., Fujii, S., Rino, Y., Kunisaki, C., et al. (2008). Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulinlike growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oncol. Rep. 20, 359-364.
19. Rath, T., Roderfeld, M., Graf, J., Wagner, S., Vehr, A.K., Dietrich, C., Geier, A., and Roeb, E. (2006). Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential? Inflamm. Bowel Dis. 12, 1025-1035.
20. Shinkai, Y. and Alt, F.W. (1994). CD3 epsilon-mediated signals rescue the development of CD4qCD8q thymocytes in RAG- 2-/- mice in the absence of TCR beta chain expression. Int. Immunol. 6, 995-1001.
21. Strand, S., Vollmer, P., van den Abeelen, L., Gottfried, D., Alla, V., Heid, H., Kuball, J., Theobald, M., Galle, P.R., and Strand, D. (2004). Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells. Oncogene 23, 3732-3736.
22. Visse, R. and Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
23. Yoshimoto, M., Itoh, F., Yamamoto, H., Hinoda, Y., Imai, K., and Yachi, A. (1993). Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancers. Int. J. Cancer 54, 614-618.